C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
01/1998
01/06/1998	US5705606 Polypeptides for binding aggregation mediators such as fibrogen
01/06/1998	US5705486 Anticoagulants for blood disorders
01/06/1998	US5705481 Arginine-containing pentpeptides
01/06/1998	CA1339623C Lhrh antagonists
01/06/1998	CA1339622C Oncofetal fibronectin epitope
01/01/1998	CA2205543A1 Peptides and peptidomimetic compounds affecting the activity of g-protein-coupled receptors by altering receptor oligomerization
12/1997
12/31/1997	WO1997049724A1 Cyclic depsipeptides and drugs containing the same as the active ingredient
12/31/1997	WO1997049722A1 Depsipeptides and drugs containing the same as the active ingredient
12/31/1997	WO1997049430A1 Immunotherapy by modulation of antigen presentation
12/31/1997	WO1997049425A1 Vaccine comprising antigens bound to carriers through labile bonds
12/31/1997	WO1997049419A1 Ophthalmic drug compositions
12/31/1997	WO1997049417A1 Isolated, nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof
12/31/1997	CA2259159A1 Depsipeptides and drugs containing the same as the active ingredient
12/31/1997	CA2259124A1 Isolated, nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof
12/31/1997	CA2258487A1 Cyclic depsipeptides and drugs containing the same as the active ingredient
12/30/1997	US5703207 Protein active in humoral hypercalcemia of malignancy-PTHrP
12/30/1997	US5703205 Laminin a chain polypeptides from the amino terminal golbular domain
12/30/1997	US5702909 Methods of detecting collagen type II degradation in vivo
12/30/1997	US5702904 Immunoassay for identifying alcoholics and monitoring alcohol consumption
12/30/1997	CA1339606C Polypeptides complementary to peptides or proteins having an amino acid sequence or necleotide coding sequence at least partially known
12/29/1997	EP0813876A1 Cyclosporin-containing soft capsule preparations
12/29/1997	EP0813610A1 Sequence-specific detection of nucleic acids
12/29/1997	EP0813544A1 Bradykinin antagonist peptides incorporating n-substituted glycines
12/28/1997	CA2206663A1 Peptides which bind to prothrombin and thrombin
12/24/1997	WO1997048976A2 Method for discovering novel anthelmintic compounds
12/24/1997	WO1997048728A1 Il-6 and il-6-receptor derived peptides having il-6 antagonistic or agonistic activity
12/24/1997	WO1997048726A1 Method for producing peptides
12/24/1997	WO1997048410A1 Cyclosporin-containing soft capsule preparations
12/24/1997	CN1168695A Inhibitor of stem cell proliferation and uses thereof
12/24/1997	CN1168677A Novel peptides derived from autoantigent for use in immunotherapy of autoimmune diseases
12/24/1997	CN1168675A New compound
12/24/1997	CN1168674A Synthetic peptides and vaccines comprising same
12/23/1997	US5700922 PNA-DNA-PNA chimeric macromolecules
12/23/1997	US5700909 For stimulating neural cell outgrowth
12/23/1997	US5700906 Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein
12/23/1997	US5700905 Hexapeptides, cyclic peptides; as binding g-protein-linked receptors
12/23/1997	US5700780 Oligopeptide viricides; ribonucleotide reductase enzyme inhibitor
12/23/1997	US5700779 Bradykinin antagonist peptides incorporating N-substituted glycines
12/23/1997	US5700635 HIV-1 gag cytotoxic T-lymphocyte epitope and method of use
12/23/1997	US5700444 Metallopeptide for drug delivery, diagnosis, treating infections, inflammations, diseases
12/23/1997	CA2084663C Non-hygroscopic mono-ammonium salts
12/18/1997	WO1997047750A1 IL-1/TNF-α-ACTIVATED KINASE (ITAK), AND METHODS OF MAKING AND USING THE SAME
12/18/1997	WO1997047738A1 Cyclic lipopeptide acylase
12/18/1997	WO1997047645A1 A process for preparing certain aza cyclohexapeptides
12/18/1997	WO1997047644A1 T cell antigen receptor peptides
12/18/1997	WO1997047313A1 Total synthesis of bacitracin polypetides
12/18/1997	WO1997047312A1 Novel heparin binding peptides
12/18/1997	CA2257614A1 Novel heparin binding peptides
12/18/1997	CA2257373A1 Il-1/tnf-.alpha.-activated kinase (itak), and methods of making and using the same
12/17/1997	EP0812330A2 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use
12/17/1997	CN1168143A Antitumor agents isolated from intestinal mucosa, method for their isolation and their application
12/17/1997	CN1168142A Novel peptides, their production and use
12/17/1997	CN1036715C Cyclic peptide deriv. antifungal agents, and process for preparation thereof, and medicinal preparation contg. it
12/16/1997	US5698673 Peptides having anti-melittin activity
12/16/1997	US5698522 6-position modified decapeptide LHRH antagonists
12/16/1997	US5698516 Biologically active vasopressin analogues
12/11/1997	WO1997046582A1 Meningococcal vaccine
12/11/1997	WO1997046580A1 Antibiotic producing microbe
12/11/1997	WO1997046579A1 Neuropeptide y agonists
12/11/1997	WO1997046578A1 Peptide derivatives
12/11/1997	WO1997046575A1 Method of isolating cyclosporins
12/11/1997	WO1997046259A2 Chimeric toxin for targeted therapy
12/11/1997	WO1997046251A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES
12/11/1997	WO1997046248A1 Cyclic polypeptides comprising a thioether linkage and methods for their preparation
12/11/1997	WO1997041443A3 Method for screening compounds
12/11/1997	CA2257424A1 Neuropeptide y agonists
12/11/1997	CA2256449A1 Apl immunoreactive peptides, conjugates thereof and methods of treatment for apl antibody-mediated pathologies
12/11/1997	CA2252417A1 Peptide derivatives
12/11/1997	CA2251536A1 Cyclic polypeptides comprising a thioether linkage and methods for their preparation
12/10/1997	EP0811686A2 Human platelet-derived growth factor receptors
12/10/1997	EP0811685A2 Human platelet-derived growth factor receptors
12/10/1997	EP0811076A1 ISOLATED NUCLEIC ACID MOLECULE ENCODING PEPTIDES WHICH FORM COMPLEXES WITH MHC MOLECULE HLA-Cw*1601 AND USES THEREOF
12/10/1997	EP0811013A1 Isolated nonapeptides presented by hla molecules, and uses thereof
12/10/1997	EP0810870A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof
12/10/1997	EP0504335B1 A fibronectin binding peptide
12/09/1997	US5696084 Amino-lipopetide antifungal agents
12/09/1997	US5695994 Isolated cytolytic T cells specific for complexes of MAGE related peptides and HLA molecules
12/09/1997	US5695766 Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
12/09/1997	CA2024855C Process and intermediates for producing glucagon
12/04/1997	WO1997045743A1 A method for selecting target pathogen inhibiting substances and test kits for use therein
12/04/1997	WO1997045444A1 Ebv ctl epitopes
12/04/1997	WO1997045128A1 Apoptosis associated protein bbk
12/04/1997	WO1997040065A3 Substrates and inhibitors of proteolytic enzymes
12/04/1997	CA2256372A1 Apoptosis associated protein bbk
12/04/1997	CA2255927A1 Ebv ctl epitopes
12/03/1997	EP0809656A1 MONOCLONAL ANTIBODY SPECIFIC FOR $g(b)A4 PEPTIDE
12/03/1997	EP0809653A1 Helicobacter pylori antigen
12/03/1997	EP0646242A4 Non-radioactive enzyme assay.
12/03/1997	EP0600866B1 Compositions and methods for identifying biologically active molecules
12/03/1997	EP0590055B1 M-protein peptides of influenza virus as antiviral agents
12/02/1997	US5693753 Method of isolating βA4 peptide species ending at carboxy-terminals residue 42 using monoclonal antibody 369.2B
12/02/1997	US5693752 Hexapeptides of specified amino acid sequences
12/02/1997	US5693750 Microbiocidal action against pneumocystis infections
12/02/1997	US5693679 Fluorescent somatostatin
12/02/1997	US5693612 Used for prophylaxis and treatment of disorders of the circulation, bones and in tumor therapy, and as antimicrobial and antiviral active compounds
12/02/1997	US5693611 Cyclic peptide antifungal agents
12/02/1997	US5693502 Nucleic acid ligand inhibitors to DNA polymerases
12/02/1997	US5693491 Isolated and purified polynucleotide comprising nucleotide sequence encoding receptor having specified amino acid sequence
12/02/1997	US5693486 Microbiocides against escherichia, listeria, candida; contact lens antiseptic
12/02/1997	US5693477 Receptor membranes

1 ... 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 ... 423